SSA
GH icon

Schonfeld Strategic Advisors’s Guardant Health GH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9M Buy
179,482
+107,798
+150% +$11.7M 0.1% 185
2026
Q1 		$6.62M Buy
71,684
+66,603
+1,311% +$6.69M 0.05% 412
2025
Q4 		$519K Sell
5,081
-16,401
-76% -$1.47M ﹤0.01% 1382
2025
Q3 		$1.34M Sell
21,482
-17,734
-45% -$965K 0.01% 1240
2025
Q2 		$2.04M Buy
+39,216
New +$1.75M 0.01% 971
2025
Q1 		– Sell
-28,250
Closed -$863K – 2304
2024
Q4 		$863K Buy
+28,250
New +$795K 0.01% 1180
2023
Q3 		– Sell
-33,900
Closed -$1.21M – 1955
2023
Q2 		$1.21M Buy
+33,900
New +$974K 0.01% 912
2023
Q1 		– Sell
-134,248
Closed -$3.65M – 2286
2022
Q4 		$3.65M Buy
134,248
+33,071
+33% +$1.51M 0.03% 582
2022
Q3 		$5.45M Buy
101,177
+16,381
+19% +$841K 0.05% 504
2022
Q2 		$3.42M Buy
84,796
+59,793
+239% +$2.96M 0.03% 576
2022
Q1 		$1.66M Sell
25,003
-19,017
-43% -$1.3M 0.01% 803
2021
Q4 		$4.4M Buy
+44,020
New +$4.55M 0.04% 501
2021
Q2 		– Sell
-22,654
Closed -$3.46M – 2067
2021
Q1 		$3.46M Buy
22,654
+18,299
+420% +$2.77M 0.04% 531
2020
Q4 		$561K Buy
4,355
+1,081
+33% +$124K 0.01% 1006
2020
Q3 		$366K Buy
+3,274
New +$300K 0.01% 1018
2019
Q4 		– Sell
-6,637
Closed -$424K – 1364
2019
Q3 		$424K Sell
6,637
-12,063
-65% -$1.06M 0.01% 690
2019
Q2 		$1.61M Buy
+18,700
New +$1.43M 0.06% 337
2019
Q1 		– Sell
-95,700
Closed -$3.6M – 1107
2018
Q4 		$3.6M Buy
+95,700
New +$3.53M 0.14% 206

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Schonfeld Strategic Advisors's GH Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Guardant Health (GH) stake by 150% in Q2 2026, buying an estimated $11.7M and bringing the position to 179,482 shares worth $26.9M. The position accounts for 0.1% of the portfolio, ranked #185.

Schonfeld Strategic Advisors first reported a position in GH in Q4 2018 and has held it in 18 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Schonfeld Strategic Advisors held 179,482 shares of Guardant Health worth $26.9M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 107,798 Guardant Health shares in Q2 2026, an estimated $11.7M.
  • Guardant Health made up 0.1% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #185 holding.
  • Schonfeld Strategic Advisors first reported a position in Guardant Health in Q4 2018 and has held it in 18 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.